SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biomerica Inc. – ‘10-Q’ for 2/29/24 – ‘JSON’

On:  Friday, 4/12/24, at 5:00pm ET   ·   For:  2/29/24   ·   Accession #:  1493152-24-14474   ·   File #:  1-37863

Previous ‘10-Q’:  ‘10-Q’ on 1/16/24 for 11/30/23   ·   Latest ‘10-Q’:  This Filing   ·   1 Reference:  By:  Biomerica Inc. – ‘424B5’ on 5/10/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/12/24  Biomerica Inc.                    10-Q        2/29/24   43:3.5M                                   M2 Compliance LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    786K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
11: R1          Cover                                               HTML     66K 
12: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    112K 
13: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     39K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML    104K 
                and Comprehensive Loss (Unaudited)                               
15: R5          Condensed Consolidated Statements of Shareholders'  HTML     76K 
                Equity (Unaudited)                                               
16: R6          Condensed Consolidated Statements of Cash Flows     HTML     98K 
                (Unaudited)                                                      
17: R7          Basis of Presentation                               HTML     26K 
18: R8          Significant Accounting Policies                     HTML    120K 
19: R9          Shareholders? Equity                                HTML     26K 
20: R10         Geographic Information                              HTML     33K 
21: R11         Leases                                              HTML     38K 
22: R12         Commitments and Contingencies                       HTML     18K 
23: R13         Subsequent Events                                   HTML     16K 
24: R14         Significant Accounting Policies (Policies)          HTML    176K 
25: R15         Significant Accounting Policies (Tables)            HTML     43K 
26: R16         Geographic Information (Tables)                     HTML     26K 
27: R17         Leases (Tables)                                     HTML     36K 
28: R18         Schedule of Net Inventories (Details)               HTML     26K 
29: R19         Summary of Options Activity (Details)               HTML     28K 
30: R20         Schedule of Disaggregation Revenue (Details)        HTML     28K 
31: R21         Significant Accounting Policies (Details            HTML    147K 
                Narrative)                                                       
32: R22         Shareholders? Equity (Details Narrative)            HTML     31K 
33: R23         Schedule of Geographic Information (Details)        HTML     34K 
34: R24         Geographic Information (Details Narrative)          HTML     24K 
35: R25         Schedule of Operating Leases (Details)              HTML     23K 
36: R26         Schedule of Future Minimum Lease Payments           HTML     26K 
                (Details)                                                        
37: R27         Schedule of Other Supplemental Lease Information    HTML     20K 
                (Details)                                                        
38: R28         Leases (Details Narrative)                          HTML     19K 
40: XML         IDEA XML File -- Filing Summary                      XML     66K 
43: XML         XBRL Instance -- form10-q_htm                        XML    836K 
39: EXCEL       IDEA Workbook of Financial Report Info              XLSX     82K 
 7: EX-101.CAL  XBRL Calculations -- bmra-20240229_cal               XML    118K 
 8: EX-101.DEF  XBRL Definitions -- bmra-20240229_def                XML    240K 
 9: EX-101.LAB  XBRL Labels -- bmra-20240229_lab                     XML    596K 
10: EX-101.PRE  XBRL Presentations -- bmra-20240229_pre              XML    432K 
 6: EX-101.SCH  XBRL Schema -- bmra-20240229                         XSD     66K 
41: JSON        XBRL Instance as JSON Data -- MetaLinks              291±   409K 
42: ZIP         XBRL Zipped Folder -- 0001493152-24-014474-xbrl      Zip    155K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"version":  "2.2",
"instance":  {
    "form10-q.htm":  {
        "nsprefix":  "BMRA",
        "nsuri":  "http://biomerica.com/20240229",
        "dts":  {
            "schema":  {
                "local":  [
                    "bmra-20240229.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
                    "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
                    "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
                    "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
                    "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
                    "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
                    "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
                    "https://xbrl.sec.gov/country/2023/country-2023.xsd",
                    "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
                    ]
                },
            "calculationLink":  {
                "local":  [
                    "bmra-20240229_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "bmra-20240229_def.xml"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "bmra-20240229_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "bmra-20240229_pre.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "form10-q.htm"
                    ]
                }
            },
        "keyStandard":  191,
        "keyCustom":  11,
        "axisStandard":  14,
        "axisCustom":  0,
        "memberStandard":  22,
        "memberCustom":  15,
        "hidden":  {
            "total":  88,
            "http://fasb.org/us-gaap/2023":  82,
            "http://biomerica.com/20240229":  2,
            "http://xbrl.sec.gov/dei/2023":  4
            },
        "contextCount":  148,
        "entityCount":  1,
        "segmentCount":  38,
        "elementCount":  333,
        "unitCount":  6,
        "baseTaxonomies":  {
            "http://fasb.org/us-gaap/2023":  598,
            "http://xbrl.sec.gov/dei/2023":  29
            },
        "report":  {
            "R1":  {
                "role":  "http://biomerica.com/role/Cover",
                "longName":  "00000001 - Document - Cover",
                "shortName":  "Cover",
                "isDefault":  "true",
                "groupType":  "document",
                "subGroupType":  "",
                "menuCat":  "Cover",
                "order":  "1",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "dei:DocumentType",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "dei:DocumentType",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R2":  {
                "role":  "http://biomerica.com/role/BalanceSheets",
                "longName":  "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
                "shortName":  "Condensed Consolidated Balance Sheets (Unaudited)",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "2",
                "firstAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:AccountsReceivableNetCurrent",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R3":  {
                "role":  "http://biomerica.com/role/BalanceSheetsParenthetical",
                "longName":  "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
                "shortName":  "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "parenthetical",
                "menuCat":  "Statements",
                "order":  "3",
                "firstAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "BMRA:OperatingLeaseRightOfUseAssetAccumulatedAmortization",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "BMRA:OperatingLeaseRightOfUseAssetAccumulatedAmortization",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R4":  {
                "role":  "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss",
                "longName":  "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
                "shortName":  "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "4",
                "firstAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:Revenues",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:CostOfRevenue",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R5":  {
                "role":  "http://biomerica.com/role/StatementsOfShareholdersEquity",
                "longName":  "00000005 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
                "shortName":  "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "5",
                "firstAnchor":  {
                    "contextRef":  "AsOf2022-05-31_us-gaap_CommonStockMember",
                    "name":  "us-gaap:StockholdersEquity",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2022-06-012022-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember",
                    "name":  "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R6":  {
                "role":  "http://biomerica.com/role/StatementsOfCashFlows",
                "longName":  "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
                "shortName":  "Condensed Consolidated Statements of Cash Flows (Unaudited)",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "6",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:NetIncomeLoss",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:DepreciationAndAmortization",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R7":  {
                "role":  "http://biomerica.com/role/BasisOfPresentation",
                "longName":  "00000007 - Disclosure - BASIS OF PRESENTATION",
                "shortName":  "BASIS OF PRESENTATION",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "7",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:BasisOfAccounting",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:BasisOfAccounting",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R8":  {
                "role":  "http://biomerica.com/role/SignificantAccountingPolicies",
                "longName":  "00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
                "shortName":  "SIGNIFICANT ACCOUNTING POLICIES",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "8",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R9":  {
                "role":  "http://biomerica.com/role/ShareholdersEquity",
                "longName":  "00000009 - Disclosure - SHAREHOLDERS\u2019 EQUITY",
                "shortName":  "SHAREHOLDERS\u2019 EQUITY",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "9",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R10":  {
                "role":  "http://biomerica.com/role/GeographicInformation",
                "longName":  "00000010 - Disclosure - GEOGRAPHIC INFORMATION",
                "shortName":  "GEOGRAPHIC INFORMATION",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "10",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R11":  {
                "role":  "http://biomerica.com/role/Leases",
                "longName":  "00000011 - Disclosure - LEASES",
                "shortName":  "LEASES",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "11",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R12":  {
                "role":  "http://biomerica.com/role/CommitmentsAndContingencies",
                "longName":  "00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES",
                "shortName":  "COMMITMENTS AND CONTINGENCIES",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "12",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R13":  {
                "role":  "http://biomerica.com/role/SubsequentEvents",
                "longName":  "00000013 - Disclosure - SUBSEQUENT EVENTS",
                "shortName":  "SUBSEQUENT EVENTS",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "13",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R14":  {
                "role":  "http://biomerica.com/role/SignificantAccountingPoliciesPolicies",
                "longName":  "00000014 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
                "shortName":  "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "policies",
                "menuCat":  "Policies",
                "order":  "14",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:ConsolidationPolicyTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:ConsolidationPolicyTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R15":  {
                "role":  "http://biomerica.com/role/SignificantAccountingPoliciesTables",
                "longName":  "00000015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
                "shortName":  "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "15",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:InventoryPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:InventoryPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R16":  {
                "role":  "http://biomerica.com/role/GeographicInformationTables",
                "longName":  "00000016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)",
                "shortName":  "GEOGRAPHIC INFORMATION (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "16",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R17":  {
                "role":  "http://biomerica.com/role/LeasesTables",
                "longName":  "00000017 - Disclosure - LEASES (Tables)",
                "shortName":  "LEASES (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "17",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R18":  {
                "role":  "http://biomerica.com/role/ScheduleOfNetInventoriesDetails",
                "longName":  "00000018 - Disclosure - SCHEDULE OF NET INVENTORIES (Details)",
                "shortName":  "SCHEDULE OF NET INVENTORIES (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "18",
                "firstAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:InventoryRawMaterialsAndSupplies",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                        "us-gaap:InventoryPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:InventoryRawMaterialsAndSupplies",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                        "us-gaap:InventoryPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R19":  {
                "role":  "http://biomerica.com/role/SummaryOfOptionsActivityDetails",
                "longName":  "00000019 - Disclosure - SUMMARY OF OPTIONS ACTIVITY (Details)",
                "shortName":  "SUMMARY OF OPTIONS ACTIVITY (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "19",
                "firstAnchor":  {
                    "contextRef":  "AsOf2023-05-31",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "unitRef":  "Shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "AsOf2023-05-31",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "unitRef":  "Shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R20":  {
                "role":  "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails",
                "longName":  "00000020 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)",
                "shortName":  "SCHEDULE OF DISAGGREGATION REVENUE (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "20",
                "firstAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "us-gaap:RevenueRecognitionPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DisaggregationOfRevenueTableTextBlock",
                        "us-gaap:RevenueRecognitionPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R21":  {
                "role":  "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative",
                "longName":  "00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
                "shortName":  "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "21",
                "firstAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:RetainedEarningsAccumulatedDeficit",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-09-272023-09-27",
                    "name":  "BMRA:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "BMRA:LiquidityPolicyTextBlock",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R22":  {
                "role":  "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                "longName":  "00000022 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)",
                "shortName":  "SHAREHOLDERS\u2019 EQUITY (Details Narrative)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "22",
                "firstAnchor":  {
                    "contextRef":  "From2022-06-012023-02-28",
                    "name":  "us-gaap:ProceedsFromIssuanceOfCommonStock",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-03-012023-03-31_us-gaap_CommonStockMember",
                    "name":  "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
                    "unitRef":  "Shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R23":  {
                "role":  "http://biomerica.com/role/ScheduleOfGeographicInformationDetails",
                "longName":  "00000023 - Disclosure - SCHEDULE OF GEOGRAPHIC INFORMATION (Details)",
                "shortName":  "SCHEDULE OF GEOGRAPHIC INFORMATION (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "23",
                "firstAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:Revenues",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29_srt_AsiaMember",
                    "name":  "us-gaap:Revenues",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "unique":  true
                    }
                },
            "R24":  {
                "role":  "http://biomerica.com/role/GeographicInformationDetailsNarrative",
                "longName":  "00000024 - Disclosure - GEOGRAPHIC INFORMATION (Details Narrative)",
                "shortName":  "GEOGRAPHIC INFORMATION (Details Narrative)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "24",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "unitRef":  "Segment",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "unitRef":  "Segment",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R25":  {
                "role":  "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails",
                "longName":  "00000025 - Disclosure - SCHEDULE OF OPERATING LEASES (Details)",
                "shortName":  "SCHEDULE OF OPERATING LEASES (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "25",
                "firstAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:OperatingLeaseCost",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LeaseCostTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-12-012024-02-29",
                    "name":  "us-gaap:OperatingLeaseCost",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LeaseCostTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R26":  {
                "role":  "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails",
                "longName":  "00000026 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)",
                "shortName":  "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "26",
                "firstAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "AsOf2024-02-29",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R27":  {
                "role":  "http://biomerica.com/role/ScheduleOfOtherSupplementalLeaseInformationDetails",
                "longName":  "00000027 - Disclosure - SCHEDULE OF OTHER SUPPLEMENTAL LEASE INFORMATION (Details)",
                "shortName":  "SCHEDULE OF OTHER SUPPLEMENTAL LEASE INFORMATION (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "27",
                "firstAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:OperatingLeasePayments",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "BMRA:ScheduleOfSupplementalLeaseInformationTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "From2023-06-01to2024-02-29",
                    "name":  "us-gaap:OperatingLeasePayments",
                    "unitRef":  "USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "BMRA:ScheduleOfSupplementalLeaseInformationTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R28":  {
                "role":  "http://biomerica.com/role/LeasesDetailsNarrative",
                "longName":  "00000028 - Disclosure - LEASES (Details Narrative)",
                "shortName":  "LEASES (Details Narrative)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "28",
                "firstAnchor":  {
                    "contextRef":  "AsOf2016-11-30",
                    "name":  "us-gaap:AreaOfLand",
                    "unitRef":  "Sqft",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "us-gaap:LesseeOperatingLeaseDescription",
                        "span",
                        "span",
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "AsOf2016-11-30",
                    "name":  "us-gaap:AreaOfLand",
                    "unitRef":  "Sqft",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "us-gaap:LesseeOperatingLeaseDescription",
                        "span",
                        "span",
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "form10-q.htm",
                    "first":  true,
                    "unique":  true
                    }
                }
            },
        "tag":  {
            "BMRA_ATMAgreementMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ATMAgreementMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ATM Agreement [Member]",
                            "documentation":  "ATM Agreement [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_ATMOfferingMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ATMOfferingMember",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ATM Offering [Member]",
                            "documentation":  "ATM Offering [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountingPoliciesAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsPayableAndAccruedLiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts payable and accrued expenses",
                            "documentation":  "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
                            }
                        }
                    },
                "auth_ref":  [
                    "r19"
                    ]
                },
            "us-gaap_AccountsPayableMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsPayableMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts Payable [Member]",
                            "documentation":  "Obligations incurred and payable to vendors for goods and services received."
                            }
                        }
                    },
                "auth_ref":  [
                    "r17"
                    ]
                },
            "BMRA_AccountsReceivableCreditLossExpenseReversal":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "AccountsReceivableCreditLossExpenseReversal",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts receivable, credit loss expense (Reversal)",
                            "documentation":  "Accounts receivable credit loss expense reversal."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AccountsReceivableMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsReceivableMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts Receivable [Member]",
                            "documentation":  "Due from customers or clients for goods or services that have been delivered or sold."
                            }
                        }
                    },
                "auth_ref":  [
                    "r486"
                    ]
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsReceivableNetCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts receivable, net",
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
                            }
                        }
                    },
                "auth_ref":  [
                    "r198",
                    "r199"
                    ]
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accumulated other comprehensive loss",
                            "documentation":  "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
                            }
                        }
                    },
                "auth_ref":  [
                    "r25",
                    "r26",
                    "r72",
                    "r125",
                    "r364",
                    "r386",
                    "r387"
                    ]
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccumulatedOtherComprehensiveIncomeMember",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "AOCI Attributable to Parent [Member]",
                            "documentation":  "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent.  Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
                            }
                        }
                    },
                "auth_ref":  [
                    "r2",
                    "r9",
                    "r26",
                    "r297",
                    "r300",
                    "r331",
                    "r382",
                    "r383",
                    "r563",
                    "r564",
                    "r565",
                    "r570",
                    "r571",
                    "r572"
                    ]
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdditionalPaidInCapital",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional paid-in capital",
                            "documentation":  "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder.  Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
                            }
                        }
                    },
                "auth_ref":  [
                    "r64",
                    "r516",
                    "r602"
                    ]
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdditionalPaidInCapitalMember",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Paid-in Capital [Member]",
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
                            }
                        }
                    },
                "auth_ref":  [
                    "r271",
                    "r272",
                    "r273",
                    "r399",
                    "r570",
                    "r571",
                    "r572",
                    "r585",
                    "r603"
                    ]
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based compensation",
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r52",
                    "r53",
                    "r256"
                    ]
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AdvertisingCostsPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdvertisingCostsPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ADVERTISING COSTS",
                            "documentation":  "Disclosure of accounting policy for advertising cost."
                            }
                        }
                    },
                "auth_ref":  [
                    "r102"
                    ]
                },
            "us-gaap_AdvertisingExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdvertisingExpense",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Advertising expense",
                            "documentation":  "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
                            }
                        }
                    },
                "auth_ref":  [
                    "r279"
                    ]
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AllocatedShareBasedCompensationExpense",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-based payment arrangement, expense",
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized."
                            }
                        }
                    },
                "auth_ref":  [
                    "r270",
                    "r278"
                    ]
                },
            "dei_AmendmentDescription":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AmendmentDescription",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amendment Description",
                            "documentation":  "Description of changes contained within amended document."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_AmendmentFlag":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AmendmentFlag",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amendment Flag",
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AmortizationOfIntangibleAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AmortizationOfIntangibleAssets",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amortization of intangible assets",
                            "documentation":  "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6",
                    "r45",
                    "r49"
                    ]
                },
            "dei_AnnualInformationForm":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AnnualInformationForm",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Annual Information Form",
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing an annual information form."
                            }
                        }
                    },
                "auth_ref":  [
                    "r544"
                    ]
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Antidilutive securities excluded from computation of earnings per share, amount (in shares)",
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
                            }
                        }
                    },
                "auth_ref":  [
                    "r167"
                    ]
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Antidilutive Securities [Axis]",
                            "documentation":  "Information by type of antidilutive security."
                            }
                        }
                    },
                "auth_ref":  [
                    "r33"
                    ]
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
                            }
                        }
                    },
                "auth_ref":  [
                    "r33"
                    ]
                },
            "us-gaap_AreaOfLand":  {
                "xbrltype":  "areaItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AreaOfLand",
                "presentation":  [
                    "http://biomerica.com/role/LeasesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Area of land",
                            "documentation":  "Area of land held."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_AsiaMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "AsiaMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Asia [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r605",
                    "r606",
                    "r607",
                    "r608"
                    ]
                },
            "us-gaap_Assets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Assets",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total Assets",
                            "label":  "Assets [Default Label]",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
                            }
                        }
                    },
                "auth_ref":  [
                    "r92",
                    "r120",
                    "r145",
                    "r176",
                    "r184",
                    "r189",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r292",
                    "r294",
                    "r306",
                    "r360",
                    "r436",
                    "r516",
                    "r529",
                    "r580",
                    "r581",
                    "r591"
                    ]
                },
            "us-gaap_AssetsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetsAbstract",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AssetsCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetsCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total current assets",
                            "label":  "Assets, Current",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
                            }
                        }
                    },
                "auth_ref":  [
                    "r114",
                    "r128",
                    "r145",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r292",
                    "r294",
                    "r306",
                    "r516",
                    "r580",
                    "r581",
                    "r591"
                    ]
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetsCurrentAbstract",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Assets:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_AuditedAnnualFinancialStatements":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AuditedAnnualFinancialStatements",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Audited Annual Financial Statements",
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r544"
                    ]
                },
            "us-gaap_BasisOfAccounting":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "BasisOfAccounting",
                "presentation":  [
                    "http://biomerica.com/role/BasisOfPresentation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "BASIS OF PRESENTATION",
                            "documentation":  "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r84"
                    ]
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash and cash equivalents",
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r30",
                    "r117",
                    "r502"
                    ]
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CASH AND CASH EQUIVALENTS",
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    "r31"
                    ]
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "periodStartLabel":  "Cash and cash equivalents at beginning of year",
                            "periodEndLabel":  "Cash and cash equivalents at end of period",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r30",
                    "r81",
                    "r142"
                    ]
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Net decrease in cash and cash equivalents",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r1",
                    "r81"
                    ]
                },
            "BMRA_CashPaidDuringYearForAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "CashPaidDuringYearForAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash paid during the period for:",
                            "documentation":  "Cash Paid During Year For [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_CityAreaCode":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CityAreaCode",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "City Area Code",
                            "documentation":  "Area code of city"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ClassOfStockDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ClassOfStockDomain",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
                            }
                        }
                    },
                "auth_ref":  [
                    "r111",
                    "r121",
                    "r122",
                    "r123",
                    "r145",
                    "r161",
                    "r162",
                    "r164",
                    "r166",
                    "r170",
                    "r171",
                    "r206",
                    "r223",
                    "r225",
                    "r226",
                    "r227",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r239",
                    "r245",
                    "r306",
                    "r394",
                    "r395",
                    "r396",
                    "r397",
                    "r399",
                    "r400",
                    "r401",
                    "r402",
                    "r403",
                    "r404",
                    "r405",
                    "r406",
                    "r407",
                    "r408",
                    "r409",
                    "r410",
                    "r424",
                    "r445",
                    "r462",
                    "r479",
                    "r480",
                    "r481",
                    "r482",
                    "r483",
                    "r550",
                    "r568",
                    "r573"
                    ]
                },
            "BMRA_ClinicalLabMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ClinicalLabMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Clinical Lab [Member]",
                            "documentation":  "Clinical Lab [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommitmentsAndContingencies",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and contingencies (Note 6)",
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
                            }
                        }
                    },
                "auth_ref":  [
                    "r23",
                    "r59",
                    "r361",
                    "r423"
                    ]
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/CommitmentsAndContingencies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "COMMITMENTS AND CONTINGENCIES",
                            "documentation":  "The entire disclosure for commitments and contingencies."
                            }
                        }
                    },
                "auth_ref":  [
                    "r87",
                    "r217",
                    "r218",
                    "r487",
                    "r577"
                    ]
                },
            "us-gaap_CommonStockMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockMember",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock [Member]",
                            "documentation":  "Stock that is subordinate to all other stock of the issuer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r519",
                    "r520",
                    "r521",
                    "r523",
                    "r524",
                    "r525",
                    "r526",
                    "r570",
                    "r571",
                    "r585",
                    "r601",
                    "r603"
                    ]
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockParOrStatedValuePerShare",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common stock, par value",
                            "documentation":  "Face amount or stated value per share of common stock."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63"
                    ]
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockSharesAuthorized",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common stock, shares authorized",
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63",
                    "r424"
                    ]
                },
            "us-gaap_CommonStockSharesIssued":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockSharesIssued",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common stock, shares issued",
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63"
                    ]
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockSharesOutstanding",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common stock, shares outstanding",
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r63",
                    "r424",
                    "r442",
                    "r603",
                    "r604"
                    ]
                },
            "us-gaap_CommonStockValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockValue",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common stock, $0.08 par value, 25,000,000 shares authorized, 16,821,646 issued and outstanding at February 29, 2024 and May 31, 2023, respectively",
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63",
                    "r363",
                    "r516"
                    ]
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ComprehensiveIncomeNetOfTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Comprehensive loss",
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners."
                            }
                        }
                    },
                "auth_ref":  [
                    "r27",
                    "r130",
                    "r132",
                    "r138",
                    "r355",
                    "r371"
                    ]
                },
            "us-gaap_ConcentrationRiskBenchmarkDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskBenchmarkDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The denominator in a calculation of a disclosed concentration risk percentage."
                            }
                        }
                    },
                "auth_ref":  [
                    "r35",
                    "r37",
                    "r57",
                    "r58",
                    "r197",
                    "r486"
                    ]
                },
            "us-gaap_ConcentrationRiskByBenchmarkAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskByBenchmarkAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Concentration Risk Benchmark [Axis]",
                            "documentation":  "Information by benchmark of concentration risk."
                            }
                        }
                    },
                "auth_ref":  [
                    "r35",
                    "r37",
                    "r57",
                    "r58",
                    "r197",
                    "r388",
                    "r486"
                    ]
                },
            "us-gaap_ConcentrationRiskByTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskByTypeAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Concentration Risk Type [Axis]",
                            "documentation":  "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
                            }
                        }
                    },
                "auth_ref":  [
                    "r35",
                    "r37",
                    "r57",
                    "r58",
                    "r197",
                    "r486",
                    "r552"
                    ]
                },
            "us-gaap_ConcentrationRiskCreditRisk":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskCreditRisk",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CONCENTRATION OF CREDIT RISK",
                            "documentation":  "Disclosure of accounting policy for credit risk."
                            }
                        }
                    },
                "auth_ref":  [
                    "r60",
                    "r105"
                    ]
                },
            "us-gaap_ConcentrationRiskPercentage1":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskPercentage1",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Concentration risk, percentage",
                            "documentation":  "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
                            }
                        }
                    },
                "auth_ref":  [
                    "r35",
                    "r37",
                    "r57",
                    "r58",
                    "r197"
                    ]
                },
            "us-gaap_ConcentrationRiskTypeDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskTypeDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
                            }
                        }
                    },
                "auth_ref":  [
                    "r35",
                    "r37",
                    "r57",
                    "r58",
                    "r197",
                    "r486"
                    ]
                },
            "us-gaap_ConsolidationPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConsolidationPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "PRINCIPLES OF CONSOLIDATION",
                            "documentation":  "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
                            }
                        }
                    },
                "auth_ref":  [
                    "r54",
                    "r504"
                    ]
                },
            "BMRA_ContractManufacturingMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ContractManufacturingMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Contract Manufacturing [Member]",
                            "documentation":  "Contract Manufacturing [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ContractWithCustomerLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ContractWithCustomerLiability",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Advance from customers",
                            "documentation":  "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
                            }
                        }
                    },
                "auth_ref":  [
                    "r247",
                    "r248",
                    "r251"
                    ]
                },
            "us-gaap_CostOfGoodsProductLineMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CostOfGoodsProductLineMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cost of Goods and Service, Product and Service Benchmark [Member]",
                            "documentation":  "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r551"
                    ]
                },
            "us-gaap_CostOfRevenue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CostOfRevenue",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Cost of sales",
                            "label":  "Cost of Revenue",
                            "documentation":  "The aggregate cost of goods produced and sold and services rendered during the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r77",
                    "r145",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r306",
                    "r580"
                    ]
                },
            "us-gaap_CostOfSalesPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CostOfSalesPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SHIPPING AND HANDLING FEES",
                            "documentation":  "Disclosure of accounting policy for cost of product sold and service rendered."
                            }
                        }
                    },
                "auth_ref":  [
                    "r555"
                    ]
                },
            "dei_CountryRegion":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CountryRegion",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Country Region",
                            "documentation":  "Region code of country"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_CoverAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CoverAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cover [Abstract]",
                            "documentation":  "Cover page."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_CurrentFiscalYearEndDate":  {
                "xbrltype":  "gMonthDayItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CurrentFiscalYearEndDate",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Fiscal Year End Date",
                            "documentation":  "End date of current fiscal year in the format --MM-DD."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CustomerConcentrationRiskMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CustomerConcentrationRiskMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer Concentration Risk [Member]",
                            "documentation":  "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues.  The risk is the materially adverse effects of loss of a significant customer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r36",
                    "r197"
                    ]
                },
            "us-gaap_DepreciationAndAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DepreciationAndAmortization",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Depreciation and amortization",
                            "documentation":  "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6",
                    "r50"
                    ]
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DepreciationDepletionAndAmortization",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Depreciation, depletion and amortization",
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6",
                    "r179"
                    ]
                },
            "us-gaap_DisaggregationOfRevenueTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DisaggregationOfRevenueTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SCHEDULE OF DISAGGREGATION REVENUE",
                            "documentation":  "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
                            }
                        }
                    },
                "auth_ref":  [
                    "r584"
                    ]
                },
            "BMRA_DisclosureLeasesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "DisclosureLeasesAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Leases",
                            "verboseLabel":  "Schedule Of Operating Leases",
                            "terseLabel":  "Schedule Of Future Minimum Lease Payments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentAccountingStandard":  {
                "xbrltype":  "accountingStandardItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentAccountingStandard",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Accounting Standard",
                            "documentation":  "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S.  GAAP', 'International Financial Reporting Standards', or 'Other'."
                            }
                        }
                    },
                "auth_ref":  [
                    "r543"
                    ]
                },
            "dei_DocumentAnnualReport":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentAnnualReport",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Annual Report",
                            "documentation":  "Boolean flag that is true only for a form used as an annual report."
                            }
                        }
                    },
                "auth_ref":  [
                    "r541",
                    "r543",
                    "r544"
                    ]
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "xbrltype":  "fiscalPeriodItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentFiscalPeriodFocus",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Fiscal Period Focus",
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentFiscalYearFocus":  {
                "xbrltype":  "gYearItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentFiscalYearFocus",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Fiscal Year Focus",
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentPeriodEndDate":  {
                "xbrltype":  "dateItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentPeriodEndDate",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Period End Date",
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentPeriodStartDate":  {
                "xbrltype":  "dateItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentPeriodStartDate",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Period Start Date",
                            "documentation":  "The start date of the period covered in the document, in YYYY-MM-DD format."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentQuarterlyReport":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentQuarterlyReport",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Quarterly Report",
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report."
                            }
                        }
                    },
                "auth_ref":  [
                    "r542"
                    ]
                },
            "dei_DocumentRegistrationStatement":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentRegistrationStatement",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Registration Statement",
                            "documentation":  "Boolean flag that is true only for a form used as a registration statement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r530"
                    ]
                },
            "dei_DocumentShellCompanyEventDate":  {
                "xbrltype":  "dateItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentShellCompanyEventDate",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Shell Company Event Date",
                            "documentation":  "Date of event requiring a shell company report."
                            }
                        }
                    },
                "auth_ref":  [
                    "r543"
                    ]
                },
            "dei_DocumentShellCompanyReport":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentShellCompanyReport",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Shell Company Report",
                            "documentation":  "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r543"
                    ]
                },
            "dei_DocumentTransitionReport":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentTransitionReport",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Transition Report",
                            "documentation":  "Boolean flag that is true only for a form used as a transition report."
                            }
                        }
                    },
                "auth_ref":  [
                    "r545"
                    ]
                },
            "dei_DocumentType":  {
                "xbrltype":  "submissionTypeItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentType",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Type",
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentsIncorporatedByReferenceTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentsIncorporatedByReferenceTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Documents Incorporated by Reference [Text Block]",
                            "documentation":  "Documents incorporated by reference."
                            }
                        }
                    },
                "auth_ref":  [
                    "r533"
                    ]
                },
            "us-gaap_EarningsPerShareBasic":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EarningsPerShareBasic",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Basic net loss per common share",
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r139",
                    "r151",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r159",
                    "r161",
                    "r164",
                    "r165",
                    "r166",
                    "r168",
                    "r304",
                    "r305",
                    "r356",
                    "r372",
                    "r507"
                    ]
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EarningsPerShareDiluted",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Diluted net loss per common share",
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r139",
                    "r151",
                    "r152",
                    "r153",
                    "r154",
                    "r155",
                    "r161",
                    "r164",
                    "r165",
                    "r166",
                    "r168",
                    "r304",
                    "r305",
                    "r356",
                    "r372",
                    "r507"
                    ]
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EarningsPerSharePolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "NET LOSS PER SHARE",
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r33",
                    "r34"
                    ]
                },
            "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effect of exchange rate changes in cash",
                            "documentation":  "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r587"
                    ]
                },
            "us-gaap_EmployeeRelatedLiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeRelatedLiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accrued compensation",
                            "documentation":  "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r21"
                    ]
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeStockOptionMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Option [Member]",
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressAddressLine1":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressAddressLine1",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Address Line One",
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressAddressLine2":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressAddressLine2",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Address Line Two",
                            "documentation":  "Address Line 2 such as Street or Suite number"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressAddressLine3":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressAddressLine3",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Address Line Three",
                            "documentation":  "Address Line 3 such as an Office Park"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressCityOrTown":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressCityOrTown",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, City or Town",
                            "documentation":  "Name of the City or Town"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressCountry":  {
                "xbrltype":  "countryCodeItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressCountry",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Country",
                            "documentation":  "ISO 3166-1 alpha-2 country code."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressPostalZipCode":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressPostalZipCode",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Postal Zip Code",
                            "documentation":  "Code for the postal or zip code"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressStateOrProvince":  {
                "xbrltype":  "stateOrProvinceItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressStateOrProvince",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, State or Province",
                            "documentation":  "Name of the state or province."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityBankruptcyProceedingsReportingCurrent":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityBankruptcyProceedingsReportingCurrent",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Bankruptcy Proceedings, Reporting Current",
                            "documentation":  "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
                            }
                        }
                    },
                "auth_ref":  [
                    "r536"
                    ]
                },
            "dei_EntityCentralIndexKey":  {
                "xbrltype":  "centralIndexKeyItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityCentralIndexKey",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Central Index Key",
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityCommonStockSharesOutstanding",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityCurrentReportingStatus":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityCurrentReportingStatus",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Current Reporting Status",
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityEmergingGrowthCompany":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityEmergingGrowthCompany",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Emerging Growth Company",
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntityExTransitionPeriod":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityExTransitionPeriod",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Elected Not To Use the Extended Transition Period",
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r549"
                    ]
                },
            "dei_EntityFileNumber":  {
                "xbrltype":  "fileNumberItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityFileNumber",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity File Number",
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityFilerCategory":  {
                "xbrltype":  "filerCategoryItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityFilerCategory",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Filer Category",
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "xbrltype":  "edgarStateCountryItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityIncorporationStateCountryCode",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Incorporation, State or Country Code",
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityInteractiveDataCurrent":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityInteractiveDataCurrent",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Interactive Data Current",
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r546"
                    ]
                },
            "dei_EntityPrimarySicNumber":  {
                "xbrltype":  "sicNumberItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityPrimarySicNumber",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Primary SIC Number",
                            "documentation":  "Primary Standard Industrial Classification (SIC) Number for the Entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r544"
                    ]
                },
            "dei_EntityPublicFloat":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityPublicFloat",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Public Float",
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityRegistrantName":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityRegistrantName",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Registrant Name",
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntityShellCompany":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityShellCompany",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Shell Company",
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntitySmallBusiness":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntitySmallBusiness",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Small Business",
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntityTaxIdentificationNumber":  {
                "xbrltype":  "employerIdItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityTaxIdentificationNumber",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Tax Identification Number",
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
                            }
                        }
                    },
                "auth_ref":  [
                    "r532"
                    ]
                },
            "dei_EntityVoluntaryFilers":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityVoluntaryFilers",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Voluntary Filers",
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityWellKnownSeasonedIssuer",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Well-known Seasoned Issuer",
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
                            }
                        }
                    },
                "auth_ref":  [
                    "r547"
                    ]
                },
            "us-gaap_EquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EquityComponentDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityComponentDomain",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r112",
                    "r134",
                    "r135",
                    "r136",
                    "r146",
                    "r147",
                    "r148",
                    "r150",
                    "r156",
                    "r158",
                    "r169",
                    "r207",
                    "r208",
                    "r246",
                    "r271",
                    "r272",
                    "r273",
                    "r289",
                    "r290",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r303",
                    "r311",
                    "r312",
                    "r313",
                    "r314",
                    "r315",
                    "r316",
                    "r331",
                    "r382",
                    "r383",
                    "r384",
                    "r399",
                    "r462"
                    ]
                },
            "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityInterestIssuedOrIssuableByTypeAxis",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Interest Type [Axis]",
                            "documentation":  "Information by type of equity interests that are issued or issuable in a business combination."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EquityInterestIssuedOrIssuableTypeDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityInterestIssuedOrIssuableTypeDomain",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of equity interest issued or issuable to acquire an entity in a business combination."
                            }
                        }
                    },
                "auth_ref":  [
                    "r91"
                    ]
                },
            "srt_EquityMethodInvesteeNameDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "EquityMethodInvesteeNameDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "auth_ref":  [
                    "r203",
                    "r204",
                    "r205"
                    ]
                },
            "us-gaap_EquityMethodInvestmentOwnershipPercentage":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityMethodInvestmentOwnershipPercentage",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity method investment, ownership percentage",
                            "documentation":  "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
                            }
                        }
                    },
                "auth_ref":  [
                    "r203"
                    ]
                },
            "srt_EuropeMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "EuropeMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Europe [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r605",
                    "r606",
                    "r607",
                    "r608"
                    ]
                },
            "dei_Extension":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "Extension",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Extension",
                            "documentation":  "Extension number for local phone number."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Class of asset."
                            }
                        }
                    },
                "auth_ref":  [
                    "r11"
                    ]
                },
            "us-gaap_FairValueByAssetClassAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueByAssetClassAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Asset Class [Axis]",
                            "documentation":  "Information by class of asset."
                            }
                        }
                    },
                "auth_ref":  [
                    "r55",
                    "r56"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetUsefulLife":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetUsefulLife",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-lived intangible asset, useful life",
                            "documentation":  "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAccumulatedAmortization",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Intangible assets, net of accumulated amortization",
                            "documentation":  "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
                            }
                        }
                    },
                "auth_ref":  [
                    "r118",
                    "r215"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]",
                            "documentation":  "Information by major type or class of finite-lived intangible assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r213",
                    "r214",
                    "r215",
                    "r216",
                    "r341",
                    "r342"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
                            }
                        }
                    },
                "auth_ref":  [
                    "r46",
                    "r48"
                    ]
                },
            "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "FOREIGN CURRENCY TRANSLATION",
                            "documentation":  "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
                            }
                        }
                    },
                "auth_ref":  [
                    "r307"
                    ]
                },
            "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "GoodwillAndIntangibleAssetsPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "INTANGIBLE ASSETS, NET",
                            "documentation":  "Disclosure of accounting policy for goodwill and intangible assets.  This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r8",
                    "r43"
                    ]
                },
            "us-gaap_GrossProfit":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "GrossProfit",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Gross (loss) profit",
                            "label":  "Gross Profit",
                            "documentation":  "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r145",
                    "r176",
                    "r183",
                    "r188",
                    "r191",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r306",
                    "r509",
                    "r580"
                    ]
                },
            "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ImpairmentOfIntangibleAssetsExcludingGoodwill",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Intangible asset impairment charges",
                            "documentation":  "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6",
                    "r15"
                    ]
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Loss before income taxes",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
                            }
                        }
                    },
                "auth_ref":  [
                    "r0",
                    "r74",
                    "r94",
                    "r176",
                    "r183",
                    "r188",
                    "r191",
                    "r357",
                    "r369",
                    "r509"
                    ]
                },
            "us-gaap_IncomeStatementAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeStatementAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxExpenseBenefit",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative",
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Provision (benefit) for income taxes",
                            "label":  "Income tax expense",
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r100",
                    "r110",
                    "r157",
                    "r158",
                    "r180",
                    "r284",
                    "r291",
                    "r374"
                    ]
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "INCOME TAXES",
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r133",
                    "r282",
                    "r283",
                    "r285",
                    "r286",
                    "r287",
                    "r288",
                    "r393"
                    ]
                },
            "us-gaap_IncomeTaxesPaidNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxesPaidNet",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income taxes",
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
                            }
                        }
                    },
                "auth_ref":  [
                    "r32"
                    ]
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  11.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Accounts payable and accrued expenses",
                            "label":  "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                            "documentation":  "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  7.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Accounts receivable",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_IncreaseDecreaseInContractWithCustomerLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInContractWithCustomerLiability",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  13.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Advance from customers",
                            "label":  "Increase (Decrease) in Contract with Customer, Liability",
                            "documentation":  "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
                            }
                        }
                    },
                "auth_ref":  [
                    "r338",
                    "r566"
                    ]
                },
            "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  12.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Accrued compensation",
                            "label":  "Increase (Decrease) in Employee Related Liabilities",
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_IncreaseDecreaseInInventories":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInInventories",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  8.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Inventories",
                            "label":  "Increase (Decrease) in Inventories",
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Changes in assets and liabilities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncreaseDecreaseInOperatingLeaseLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInOperatingLeaseLiability",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  14.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Reduction in lease liabilities",
                            "documentation":  "Amount of increase (decrease) in obligation for operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r553",
                    "r566"
                    ]
                },
            "us-gaap_IncreaseDecreaseInOtherOperatingAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInOtherOperatingAssets",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  10.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Other assets",
                            "label":  "Increase (Decrease) in Other Operating Assets",
                            "documentation":  "Amount of increase (decrease) in operating assets classified as other."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  9.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Prepaid expenses and other",
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_IntangibleAssetsNetExcludingGoodwill":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IntangibleAssetsNetExcludingGoodwill",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Intangible assets, net of accumulated amortization of $44,000 and $30,000 as of February 29, 2024 and May 31, 2023, respectively",
                            "documentation":  "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
                            }
                        }
                    },
                "auth_ref":  [
                    "r44",
                    "r47"
                    ]
                },
            "us-gaap_InterestAndDividendIncomeOperating":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InterestAndDividendIncomeOperating",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Interest and dividend income",
                            "documentation":  "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein."
                            }
                        }
                    },
                "auth_ref":  [
                    "r96",
                    "r609"
                    ]
                },
            "us-gaap_InventoryFinishedGoods":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryFinishedGoods",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails":  {
                        "parentTag":  "us-gaap_InventoryGross",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finished products",
                            "documentation":  "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r559"
                    ]
                },
            "us-gaap_InventoryGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails":  {
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative",
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total gross inventory",
                            "label":  "Inventory, gross",
                            "documentation":  "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
                            }
                        }
                    },
                "auth_ref":  [
                    "r561"
                    ]
                },
            "us-gaap_InventoryLIFOReservePeriodCharge":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryLIFOReservePeriodCharge",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Inventory reserve",
                            "documentation":  "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r86"
                    ]
                },
            "us-gaap_InventoryNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  3.0
                        },
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Inventories, net",
                            "totalLabel":  "Net inventory",
                            "documentation":  "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r127",
                    "r503",
                    "r516"
                    ]
                },
            "us-gaap_InventoryPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "INVENTORIES, NET",
                            "documentation":  "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
                            }
                        }
                    },
                "auth_ref":  [
                    "r101",
                    "r116",
                    "r126",
                    "r210",
                    "r211",
                    "r212",
                    "r339",
                    "r505"
                    ]
                },
            "us-gaap_InventoryRawMaterialsAndSupplies":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryRawMaterialsAndSupplies",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails":  {
                        "parentTag":  "us-gaap_InventoryGross",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Raw materials",
                            "documentation":  "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed."
                            }
                        }
                    },
                "auth_ref":  [
                    "r561"
                    ]
                },
            "us-gaap_InventoryValuationReserves":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryValuationReserves",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails":  {
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Inventory reserves",
                            "label":  "Inventory reserves",
                            "documentation":  "Amount of valuation reserve for inventory."
                            }
                        }
                    },
                "auth_ref":  [
                    "r42",
                    "r561"
                    ]
                },
            "us-gaap_InventoryWorkInProcess":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InventoryWorkInProcess",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails":  {
                        "parentTag":  "us-gaap_InventoryGross",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfNetInventoriesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Work in progress",
                            "documentation":  "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r560"
                    ]
                },
            "us-gaap_InvestmentPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InvestmentPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "INVESTMENTS",
                            "documentation":  "Disclosure of accounting policy for investment in financial asset."
                            }
                        }
                    },
                "auth_ref":  [
                    "r373",
                    "r389",
                    "r390",
                    "r391",
                    "r392",
                    "r470",
                    "r471"
                    ]
                },
            "us-gaap_Investments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Investments",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investments",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all investments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r359"
                    ]
                },
            "us-gaap_LeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LeaseCost",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total lease cost",
                            "label":  "Lease, Cost",
                            "documentation":  "Amount of lease cost recognized by lessee for lease contract."
                            }
                        }
                    },
                "auth_ref":  [
                    "r323",
                    "r515"
                    ]
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LeaseCostTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/LeasesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SCHEDULE OF OPERATING LEASES",
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
                            }
                        }
                    },
                "auth_ref":  [
                    "r588"
                    ]
                },
            "us-gaap_LesseeLeasesPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeLeasesPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "RIGHT-OF-USE ASSETS AND LEASE LIABILITY",
                            "documentation":  "Disclosure of accounting policy for leasing arrangement entered into by lessee."
                            }
                        }
                    },
                "auth_ref":  [
                    "r321"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseDescription":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseDescription",
                "presentation":  [
                    "http://biomerica.com/role/LeasesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease term description",
                            "documentation":  "Description of lessee's operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r322"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/LeasesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS",
                            "documentation":  "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
                            }
                        }
                    },
                "auth_ref":  [
                    "r589"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total minimum future lease payments",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r330"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "2025",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r330"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "2026",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r330"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "2024",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
                            }
                        }
                    },
                "auth_ref":  [
                    "r589"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Less: imputed interest",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r330"
                    ]
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeasesTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/Leases"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "LEASES",
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
                            }
                        }
                    },
                "auth_ref":  [
                    "r317"
                    ]
                },
            "us-gaap_Liabilities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Liabilities",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total Liabilities",
                            "label":  "Liabilities",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
                            }
                        }
                    },
                "auth_ref":  [
                    "r20",
                    "r145",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r293",
                    "r294",
                    "r295",
                    "r306",
                    "r422",
                    "r508",
                    "r529",
                    "r580",
                    "r591",
                    "r592"
                    ]
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesAndStockholdersEquity",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total Liabilities and Shareholders\u2019 Equity",
                            "label":  "Liabilities and Equity",
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
                            }
                        }
                    },
                "auth_ref":  [
                    "r68",
                    "r93",
                    "r366",
                    "r516",
                    "r569",
                    "r575",
                    "r586"
                    ]
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Shareholders\u2019 Equity"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total current liabilities",
                            "label":  "Liabilities, Current",
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r22",
                    "r115",
                    "r145",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r293",
                    "r294",
                    "r295",
                    "r306",
                    "r516",
                    "r580",
                    "r591",
                    "r592"
                    ]
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesCurrentAbstract",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Liabilities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_LiquidityPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "LiquidityPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "LIQUIDITY",
                            "documentation":  "Liquidity [Policy Text Block]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_LocalPhoneNumber":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "LocalPhoneNumber",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Local Phone Number",
                            "documentation":  "Local phone number for entity."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "country_MX":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://xbrl.sec.gov/country/2023",
                "localname":  "MX",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "MEXICO"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_MarketingAndDistributionRightsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "MarketingAndDistributionRightsMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Marketing and Distribution Rights [Member]",
                            "documentation":  "Marketing and Distribution Rights [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_MarketsAndMethodsOfDistributionPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "MarketsAndMethodsOfDistributionPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "MARKETS AND METHODS OF DISTRIBUTION",
                            "documentation":  "Markets And Methods Of Distribution [Policy Text Block]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_MaximumMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "MaximumMember",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r254",
                    "r337",
                    "r381",
                    "r414",
                    "r415",
                    "r468",
                    "r472",
                    "r474",
                    "r475",
                    "r477",
                    "r497",
                    "r498",
                    "r510",
                    "r511",
                    "r514",
                    "r518",
                    "r582",
                    "r593",
                    "r594",
                    "r595",
                    "r596",
                    "r597",
                    "r598"
                    ]
                },
            "us-gaap_MiddleEastMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "MiddleEastMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Middle East [Member]",
                            "documentation":  "Region of Middle East."
                            }
                        }
                    },
                "auth_ref":  [
                    "r605",
                    "r606",
                    "r607",
                    "r608"
                    ]
                },
            "srt_MinimumMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "MinimumMember",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r254",
                    "r337",
                    "r381",
                    "r414",
                    "r415",
                    "r468",
                    "r472",
                    "r474",
                    "r475",
                    "r477",
                    "r497",
                    "r498",
                    "r510",
                    "r511",
                    "r514",
                    "r518",
                    "r582",
                    "r593",
                    "r594",
                    "r595",
                    "r596",
                    "r597",
                    "r598"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Net cash provided by financing activities",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
                            }
                        }
                    },
                "auth_ref":  [
                    "r141"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash flows from financing activities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Net cash used in investing activities",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r141"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash flows from investing activities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Net cash used in operating activities",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
                            }
                        }
                    },
                "auth_ref":  [
                    "r81",
                    "r82",
                    "r83"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash flows from operating activities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NetIncomeLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetIncomeLoss",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows",
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Net loss",
                            "label":  "Net loss",
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
                            }
                        }
                    },
                "auth_ref":  [
                    "r75",
                    "r83",
                    "r95",
                    "r113",
                    "r129",
                    "r131",
                    "r136",
                    "r145",
                    "r149",
                    "r151",
                    "r152",
                    "r153",
                    "r154",
                    "r157",
                    "r158",
                    "r163",
                    "r176",
                    "r183",
                    "r188",
                    "r191",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r305",
                    "r306",
                    "r370",
                    "r444",
                    "r460",
                    "r461",
                    "r509",
                    "r527",
                    "r580"
                    ]
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "RECENT ACCOUNTING PRONOUNCEMENTS",
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_NoIndividualVendorMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "NoIndividualVendorMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "No Individual Vendor [Member]",
                            "documentation":  "No Individual Vendor [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_NoTradingSymbolFlag":  {
                "xbrltype":  "trueItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "NoTradingSymbolFlag",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "No Trading Symbol Flag",
                            "documentation":  "Boolean flag that is true only for a security having no trading symbol."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NoncashInvestingAndFinancingItemsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NoncashInvestingAndFinancingItemsAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Non-cash investing and financing activities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NonoperatingIncomeExpense",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total other income",
                            "label":  "Nonoperating Income (Expense)",
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r79"
                    ]
                },
            "us-gaap_NonoperatingIncomeExpenseAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NonoperatingIncomeExpenseAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other income:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_NorthAmericaMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "NorthAmericaMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "North America [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r605",
                    "r606",
                    "r607",
                    "r608"
                    ]
                },
            "us-gaap_NumberOfOperatingSegments":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NumberOfOperatingSegments",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of operating segments",
                            "documentation":  "Number of operating segments.  An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available.  An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
                            }
                        }
                    },
                "auth_ref":  [
                    "r574"
                    ]
                },
            "BMRA_OneKeyCustomerMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "OneKeyCustomerMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "One Key Customer [Member]",
                            "documentation":  "One Key Customer [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_OneKeyVendorMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "OneKeyVendorMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "One Key Vendor [Member]",
                            "documentation":  "One Key Vendor [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_OneVendorsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "OneVendorsMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "One Vendors [Member]",
                            "documentation":  "One Vendors [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingExpenses":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingExpenses",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total operating expenses",
                            "label":  "Operating Expenses",
                            "documentation":  "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services.  Includes selling, general and administrative expense."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingExpensesAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating expenses:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingIncomeLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingIncomeLoss",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Loss from operations",
                            "label":  "Operating Income (Loss)",
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues."
                            }
                        }
                    },
                "auth_ref":  [
                    "r176",
                    "r183",
                    "r188",
                    "r191",
                    "r509"
                    ]
                },
            "us-gaap_OperatingLeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseCost",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails":  {
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating lease cost",
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
                            }
                        }
                    },
                "auth_ref":  [
                    "r324",
                    "r515"
                    ]
                },
            "us-gaap_OperatingLeaseLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseLiability",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfFutureMinimumLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Total operating lease liabilities",
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r319"
                    ]
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseLiabilityCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease liabilities, current portion",
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
                            }
                        }
                    },
                "auth_ref":  [
                    "r319"
                    ]
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease liabilities, net of current portion",
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
                            }
                        }
                    },
                "auth_ref":  [
                    "r319"
                    ]
                },
            "us-gaap_OperatingLeasePayments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeasePayments",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOtherSupplementalLeaseInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash paid for operating lease liabilities",
                            "documentation":  "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
                            }
                        }
                    },
                "auth_ref":  [
                    "r320",
                    "r327"
                    ]
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseRightOfUseAsset",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Right-of-use assets, net of accumulated amortization of $835,000 and $617,000 as of February 29, 2024 and May 31, 2023, respectively",
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r318"
                    ]
                },
            "BMRA_OperatingLeaseRightOfUseAssetAccumulatedAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "OperatingLeaseRightOfUseAssetAccumulatedAmortization",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accumulated amortization",
                            "documentation":  "Accumulated amortization."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  6.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amortization of right-of-use asset",
                            "documentation":  "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r567"
                    ]
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOtherSupplementalLeaseInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted-average discount rate",
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time."
                            }
                        }
                    },
                "auth_ref":  [
                    "r329",
                    "r515"
                    ]
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOtherSupplementalLeaseInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted average remaining lease term (years)",
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r328",
                    "r515"
                    ]
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherAssetsNoncurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  6.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other assets",
                            "documentation":  "Amount of noncurrent assets classified as other."
                            }
                        }
                    },
                "auth_ref":  [
                    "r119"
                    ]
                },
            "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Foreign currency translation",
                            "documentation":  "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
                            }
                        }
                    },
                "auth_ref":  [
                    "r3",
                    "r72",
                    "r308",
                    "r309",
                    "r310"
                    ]
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other comprehensive income (loss), net of tax:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OtherReceivablesGrossCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherReceivablesGrossCurrent",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other receivables, gross, current",
                            "documentation":  "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r124"
                    ]
                },
            "dei_OtherReportingStandardItemNumber":  {
                "xbrltype":  "otherReportingStandardItemNumberItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "OtherReportingStandardItemNumber",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Reporting Standard Item Number",
                            "documentation":  "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
                            }
                        }
                    },
                "auth_ref":  [
                    "r543"
                    ]
                },
            "BMRA_OverTheCounteMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "OverTheCounteMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Over-the-counter [Member]",
                            "documentation":  "Over-the-counter [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PatentsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PatentsMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Patents [Member]",
                            "documentation":  "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
                            }
                        }
                    },
                "auth_ref":  [
                    "r90"
                    ]
                },
            "us-gaap_PaymentsOfStockIssuanceCosts":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsOfStockIssuanceCosts",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Costs from sale of common stock",
                            "label":  "Payments of Stock Issuance Costs",
                            "documentation":  "The cash outflow for cost incurred directly with the issuance of an equity security."
                            }
                        }
                    },
                "auth_ref":  [
                    "r28"
                    ]
                },
            "us-gaap_PaymentsToAcquireIntangibleAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsToAcquireIntangibleAssets",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Expenditures related to intangibles",
                            "label":  "Payments to Acquire Intangible Assets",
                            "documentation":  "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
                            }
                        }
                    },
                "auth_ref":  [
                    "r80"
                    ]
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Purchases of property and equipment",
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r80"
                    ]
                },
            "BMRA_PhysiciansOfficeMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "PhysiciansOfficeMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Physician's Office [Member]",
                            "documentation":  "Physician's Office [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_PolishDistributorMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "PolishDistributorMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Polish Distributor [Member]",
                            "documentation":  "Polish Distributor [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_PreCommencementIssuerTenderOffer":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "PreCommencementIssuerTenderOffer",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Pre-commencement Issuer Tender Offer",
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r537"
                    ]
                },
            "dei_PreCommencementTenderOffer":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "PreCommencementTenderOffer",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Pre-commencement Tender Offer",
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r538"
                    ]
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred stock, par value",
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r62",
                    "r233"
                    ]
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockSharesAuthorized",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred stock, shares authorized",
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
                            }
                        }
                    },
                "auth_ref":  [
                    "r62",
                    "r424"
                    ]
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockSharesIssued",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred stock, shares issued",
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt."
                            }
                        }
                    },
                "auth_ref":  [
                    "r62",
                    "r233"
                    ]
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockSharesOutstanding",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred stock, shares outstanding",
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased."
                            }
                        }
                    },
                "auth_ref":  [
                    "r62",
                    "r424",
                    "r442",
                    "r603",
                    "r604"
                    ]
                },
            "us-gaap_PreferredStockValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockValue",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred stock, value",
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r62",
                    "r362",
                    "r516"
                    ]
                },
            "us-gaap_PrepaidExpenseAndOtherAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PrepaidExpenseAndOtherAssets",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid expense and other assets",
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid expenses and other",
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r562"
                    ]
                },
            "BMRA_PrepaidExpensesAndOtherPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "PrepaidExpensesAndOtherPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "PREPAID EXPENSES AND OTHER",
                            "documentation":  "Prepaid Expenses and Other [Policy Text Block]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ProceedsFromCustomers":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProceedsFromCustomers",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Proceeds from customers",
                            "documentation":  "Cash receipts from customers during the current period which are usually for sales of goods and services."
                            }
                        }
                    },
                "auth_ref":  [
                    "r29"
                    ]
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative",
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Gross proceeds from sale of common stock",
                            "verboseLabel":  "Proceeds from issuance of common stock",
                            "terseLabel":  "Sale of stock, net proceeds",
                            "documentation":  "The cash inflow from the additional capital contribution to the entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r4"
                    ]
                },
            "us-gaap_ProceedsFromStockOptionsExercised":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProceedsFromStockOptionsExercised",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Proceeds from exercise of stock options",
                            "documentation":  "Amount of cash inflow from exercise of option under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r4",
                    "r14"
                    ]
                },
            "us-gaap_ProductInformationLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProductInformationLineItems",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product Information [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_ProductOrServiceAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "ProductOrServiceAxis",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Axis]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r193",
                    "r340",
                    "r375",
                    "r376",
                    "r377",
                    "r378",
                    "r379",
                    "r380",
                    "r500",
                    "r512",
                    "r517",
                    "r554",
                    "r578",
                    "r579",
                    "r584",
                    "r600"
                    ]
                },
            "srt_ProductsAndServicesDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "ProductsAndServicesDomain",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "auth_ref":  [
                    "r193",
                    "r340",
                    "r375",
                    "r376",
                    "r377",
                    "r378",
                    "r379",
                    "r380",
                    "r500",
                    "r512",
                    "r517",
                    "r554",
                    "r578",
                    "r579",
                    "r584",
                    "r600"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment [Member]",
                            "documentation":  "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property and equipment, net of accumulated depreciation and amortization",
                            "verboseLabel":  "Property and equipment, net",
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
                            }
                        }
                    },
                "auth_ref":  [
                    "r7",
                    "r358",
                    "r368",
                    "r516"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "PROPERTY AND EQUIPMENT, NET",
                            "documentation":  "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
                            }
                        }
                    },
                "auth_ref":  [
                    "r7",
                    "r106",
                    "r109",
                    "r367"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLife":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentUsefulLife",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, plant and equipment, useful life",
                            "documentation":  "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.  Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ProvisionForDoubtfulAccounts":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProvisionForDoubtfulAccounts",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Recovery for allowance on accounts receivable",
                            "documentation":  "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
                            }
                        }
                    },
                "auth_ref":  [
                    "r140",
                    "r209"
                    ]
                },
            "BMRA_PurchasedTechnologyRightsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "PurchasedTechnologyRightsMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Purchased Technology Rights [Member]",
                            "documentation":  "Purchased Technology Rights [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_RangeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "RangeAxis",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r252",
                    "r254",
                    "r266",
                    "r267",
                    "r268",
                    "r336",
                    "r337",
                    "r381",
                    "r414",
                    "r415",
                    "r468",
                    "r472",
                    "r474",
                    "r475",
                    "r477",
                    "r497",
                    "r498",
                    "r510",
                    "r511",
                    "r514",
                    "r518",
                    "r521",
                    "r576",
                    "r582",
                    "r594",
                    "r595",
                    "r596",
                    "r597",
                    "r598"
                    ]
                },
            "srt_RangeMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "RangeMember",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "auth_ref":  [
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r252",
                    "r254",
                    "r266",
                    "r267",
                    "r268",
                    "r336",
                    "r337",
                    "r381",
                    "r414",
                    "r415",
                    "r468",
                    "r472",
                    "r474",
                    "r475",
                    "r477",
                    "r497",
                    "r498",
                    "r510",
                    "r511",
                    "r514",
                    "r518",
                    "r521",
                    "r576",
                    "r582",
                    "r594",
                    "r595",
                    "r596",
                    "r597",
                    "r598"
                    ]
                },
            "us-gaap_RelatedPartyDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyDomain",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "auth_ref":  [
                    "r253",
                    "r332",
                    "r333",
                    "r417",
                    "r418",
                    "r419",
                    "r420",
                    "r421",
                    "r441",
                    "r443",
                    "r467"
                    ]
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party, Type [Axis]",
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "auth_ref":  [
                    "r253",
                    "r332",
                    "r333",
                    "r343",
                    "r344",
                    "r345",
                    "r346",
                    "r347",
                    "r348",
                    "r349",
                    "r350",
                    "r351",
                    "r352",
                    "r353",
                    "r354",
                    "r417",
                    "r418",
                    "r419",
                    "r420",
                    "r421",
                    "r441",
                    "r443",
                    "r467",
                    "r590"
                    ]
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentExpense",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative",
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Research and development",
                            "verboseLabel":  "Research and development expense",
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
                            }
                        }
                    },
                "auth_ref":  [
                    "r61",
                    "r281",
                    "r599"
                    ]
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "RESEARCH AND DEVELOPMENT",
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
                            }
                        }
                    },
                "auth_ref":  [
                    "r280"
                    ]
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accumulated deficit",
                            "negatedLabel":  "Accumulated deficit",
                            "documentation":  "Amount of accumulated undistributed earnings (deficit)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r65",
                    "r89",
                    "r365",
                    "r385",
                    "r387",
                    "r398",
                    "r425",
                    "r516"
                    ]
                },
            "us-gaap_RetainedEarningsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RetainedEarningsMember",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Retained Earnings [Member]",
                            "documentation":  "Accumulated undistributed earnings (deficit)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r112",
                    "r146",
                    "r147",
                    "r148",
                    "r150",
                    "r156",
                    "r158",
                    "r207",
                    "r208",
                    "r271",
                    "r272",
                    "r273",
                    "r289",
                    "r290",
                    "r296",
                    "r298",
                    "r299",
                    "r301",
                    "r303",
                    "r382",
                    "r384",
                    "r399",
                    "r603"
                    ]
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenues",
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
                            }
                        }
                    },
                "auth_ref":  [
                    "r177",
                    "r178",
                    "r182",
                    "r186",
                    "r187",
                    "r193",
                    "r195",
                    "r197",
                    "r249",
                    "r250",
                    "r340"
                    ]
                },
            "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SCHEDULE OF GEOGRAPHIC INFORMATION",
                            "documentation":  "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
                            }
                        }
                    },
                "auth_ref":  [
                    "r16"
                    ]
                },
            "us-gaap_RevenueRecognitionPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenueRecognitionPolicyTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "REVENUE RECOGNITION",
                            "documentation":  "Disclosure of accounting policy for revenue.  Includes revenue from contract with customer and from other sources."
                            }
                        }
                    },
                "auth_ref":  [
                    "r446",
                    "r499",
                    "r506"
                    ]
                },
            "us-gaap_Revenues":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Revenues",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative",
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net sales",
                            "verboseLabel":  "Revenues",
                            "documentation":  "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process.  Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r137",
                    "r145",
                    "r177",
                    "r178",
                    "r182",
                    "r186",
                    "r187",
                    "r193",
                    "r195",
                    "r197",
                    "r206",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r227",
                    "r228",
                    "r229",
                    "r230",
                    "r231",
                    "r306",
                    "r357",
                    "r580"
                    ]
                },
            "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative",
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenues from External Customers and Long-Lived Assets [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SaleOfStockConsiderationReceivedOnTransaction":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SaleOfStockConsiderationReceivedOnTransaction",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of stock gross proceeds",
                            "documentation":  "Cash received on stock transaction after deduction of issuance costs."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_SaleOfStockExpenses":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "SaleOfStockExpenses",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of stock expenses",
                            "documentation":  "Sale of stock expenses."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SaleOfStockNumberOfSharesIssuedInTransaction",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of stock shares issued",
                            "documentation":  "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SaleOfStockPricePerShare",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of stock, price per share",
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SalesRevenueNetMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SalesRevenueNetMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue Benchmark [Member]",
                            "documentation":  "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r197",
                    "r551"
                    ]
                },
            "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment, Name [Axis]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r203",
                    "r204",
                    "r205"
                    ]
                },
            "us-gaap_ScheduleOfInventoryCurrentTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfInventoryCurrentTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SCHEDULE OF NET INVENTORIES",
                            "documentation":  "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
                            }
                        }
                    },
                "auth_ref":  [
                    "r18",
                    "r69",
                    "r70",
                    "r71"
                    ]
                },
            "us-gaap_ScheduleOfProductInformationTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfProductInformationTable",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfDisaggregationRevenueDetails",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Product Information [Table]",
                            "documentation":  "Schedule detailing quantitative information concerning products or product lines by product or product line."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative",
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
                            "documentation":  "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries."
                            }
                        }
                    },
                "auth_ref":  [
                    "r41",
                    "r73"
                    ]
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SUMMARY OF OPTIONS ACTIVITY",
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    "r12",
                    "r13",
                    "r51"
                    ]
                },
            "BMRA_ScheduleOfSupplementalLeaseInformationTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ScheduleOfSupplementalLeaseInformationTableTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/LeasesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SCHEDULE OF OTHER SUPPLEMENTAL LEASE INFORMATION",
                            "documentation":  "Schedule of Supplemental Lease Information [Table Text Block]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_Security12bTitle":  {
                "xbrltype":  "securityTitleItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "Security12bTitle",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of 12(b) Security",
                            "documentation":  "Title of a 12(b) registered security."
                            }
                        }
                    },
                "auth_ref":  [
                    "r531"
                    ]
                },
            "dei_Security12gTitle":  {
                "xbrltype":  "securityTitleItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "Security12gTitle",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of 12(g) Security",
                            "documentation":  "Title of a 12(g) registered security."
                            }
                        }
                    },
                "auth_ref":  [
                    "r535"
                    ]
                },
            "us-gaap_SecurityDeposit":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SecurityDeposit",
                "crdr":  "debit",
                "presentation":  [
                    "http://biomerica.com/role/LeasesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Security deposit",
                            "documentation":  "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r556"
                    ]
                },
            "dei_SecurityExchangeName":  {
                "xbrltype":  "edgarExchangeCodeItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "SecurityExchangeName",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Security Exchange Name",
                            "documentation":  "Name of the Exchange on which a security is registered."
                            }
                        }
                    },
                "auth_ref":  [
                    "r534"
                    ]
                },
            "dei_SecurityReportingObligation":  {
                "xbrltype":  "securityReportingObligationItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "SecurityReportingObligation",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Security Reporting Obligation",
                            "documentation":  "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r539"
                    ]
                },
            "srt_SegmentGeographicalDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "SegmentGeographicalDomain",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative",
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "auth_ref":  [
                    "r195",
                    "r196",
                    "r411",
                    "r412",
                    "r413",
                    "r469",
                    "r473",
                    "r476",
                    "r478",
                    "r488",
                    "r489",
                    "r490",
                    "r491",
                    "r492",
                    "r493",
                    "r494",
                    "r495",
                    "r496",
                    "r501",
                    "r513",
                    "r521",
                    "r584",
                    "r600"
                    ]
                },
            "us-gaap_SegmentReportingAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SegmentReportingAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SegmentReportingDisclosureTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "GEOGRAPHIC INFORMATION",
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r172",
                    "r173",
                    "r174",
                    "r175",
                    "r176",
                    "r181",
                    "r185",
                    "r189",
                    "r190",
                    "r191",
                    "r192",
                    "r193",
                    "r194",
                    "r197"
                    ]
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss":  {
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Selling, general and administrative",
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
                            }
                        }
                    },
                "auth_ref":  [
                    "r78"
                    ]
                },
            "us-gaap_SeriesAPreferredStockMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SeriesAPreferredStockMember",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Series A Preferred Stock [Member]",
                            "documentation":  "Series A preferred stock."
                            }
                        }
                    },
                "auth_ref":  [
                    "r557",
                    "r558",
                    "r583"
                    ]
                },
            "us-gaap_ShareBasedCompensation":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensation",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/StatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Share-based compensation",
                            "label":  "Share-Based Payment Arrangement, Noncash Expense",
                            "documentation":  "Amount of noncash expense for share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                "presentation":  [
                    "http://biomerica.com/role/SummaryOfOptionsActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Options cancelled or expired",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
                            "documentation":  "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r262"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "presentation":  [
                    "http://biomerica.com/role/SummaryOfOptionsActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Options granted",
                            "documentation":  "Gross number of share options (or share units) granted during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r260"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "presentation":  [
                    "http://biomerica.com/role/SummaryOfOptionsActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "periodStartLabel":  "Option outstanding, begining balance",
                            "periodEndLabel":  "Option outstanding, ending balance",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
                            "documentation":  "Number of options outstanding, including both vested and non-vested options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r258",
                    "r259"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "presentation":  [
                    "http://biomerica.com/role/SummaryOfOptionsActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "periodStartLabel":  "Weighted average exercise price, begining balance",
                            "periodEndLabel":  "Weighted average exercise price, ending balance",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r258",
                    "r259"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://biomerica.com/role/SummaryOfOptionsActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted average exercise price, cancelled or expired",
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
                            }
                        }
                    },
                "auth_ref":  [
                    "r262"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://biomerica.com/role/SummaryOfOptionsActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted average exercise price, granted",
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r260"
                    ]
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SHARE-BASED COMPENSATION",
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost."
                            }
                        }
                    },
                "auth_ref":  [
                    "r255",
                    "r257",
                    "r263",
                    "r264",
                    "r265",
                    "r266",
                    "r269",
                    "r274",
                    "r275",
                    "r276",
                    "r277"
                    ]
                },
            "us-gaap_SharePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharePrice",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share price",
                            "documentation":  "Price of a single share of a number of saleable stocks of a company."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharesOutstanding",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "periodStartLabel":  "Balance, shares",
                            "periodEndLabel":  "Balance, shares",
                            "label":  "Shares, Outstanding",
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shelf registration statement maximum authorized common stock issuance value",
                            "documentation":  "Shelf registration statement maximum authorized common stock issuance value."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShortTermLeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShortTermLeaseCost",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails":  {
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Short-term lease cost",
                            "documentation":  "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
                            }
                        }
                    },
                "auth_ref":  [
                    "r325",
                    "r515"
                    ]
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SIGNIFICANT ACCOUNTING POLICIES",
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r84",
                    "r143"
                    ]
                },
            "dei_SolicitingMaterial":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "SolicitingMaterial",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Soliciting Material",
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r540"
                    ]
                },
            "srt_SouthAmericaMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "SouthAmericaMember",
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "South America [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r605",
                    "r606",
                    "r607",
                    "r608"
                    ]
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementClassOfStockAxis",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/BalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Class of Stock [Axis]",
                            "documentation":  "Information by the different classes of stock of the entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r111",
                    "r121",
                    "r122",
                    "r123",
                    "r145",
                    "r161",
                    "r162",
                    "r164",
                    "r166",
                    "r170",
                    "r171",
                    "r206",
                    "r223",
                    "r225",
                    "r226",
                    "r227",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r236",
                    "r239",
                    "r245",
                    "r306",
                    "r394",
                    "r395",
                    "r396",
                    "r397",
                    "r399",
                    "r400",
                    "r401",
                    "r402",
                    "r403",
                    "r404",
                    "r405",
                    "r406",
                    "r407",
                    "r408",
                    "r409",
                    "r410",
                    "r424",
                    "r445",
                    "r462",
                    "r479",
                    "r480",
                    "r481",
                    "r482",
                    "r483",
                    "r550",
                    "r568",
                    "r573"
                    ]
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementEquityComponentsAxis",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Components [Axis]",
                            "documentation":  "Information by component of equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r24",
                    "r112",
                    "r134",
                    "r135",
                    "r136",
                    "r146",
                    "r147",
                    "r148",
                    "r150",
                    "r156",
                    "r158",
                    "r169",
                    "r207",
                    "r208",
                    "r246",
                    "r271",
                    "r272",
                    "r273",
                    "r289",
                    "r290",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r303",
                    "r311",
                    "r312",
                    "r313",
                    "r314",
                    "r315",
                    "r316",
                    "r331",
                    "r382",
                    "r383",
                    "r384",
                    "r399",
                    "r462"
                    ]
                },
            "srt_StatementGeographicalAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "StatementGeographicalAxis",
                "presentation":  [
                    "http://biomerica.com/role/GeographicInformationDetailsNarrative",
                    "http://biomerica.com/role/ScheduleOfGeographicInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Geographical [Axis]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r195",
                    "r196",
                    "r411",
                    "r412",
                    "r413",
                    "r469",
                    "r473",
                    "r476",
                    "r478",
                    "r485",
                    "r488",
                    "r489",
                    "r490",
                    "r491",
                    "r492",
                    "r493",
                    "r494",
                    "r495",
                    "r496",
                    "r501",
                    "r513",
                    "r521",
                    "r584",
                    "r600"
                    ]
                },
            "us-gaap_StatementLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementLineItems",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/BalanceSheetsParenthetical",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r146",
                    "r147",
                    "r148",
                    "r169",
                    "r340",
                    "r389",
                    "r410",
                    "r416",
                    "r417",
                    "r418",
                    "r419",
                    "r420",
                    "r421",
                    "r424",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r437",
                    "r438",
                    "r439",
                    "r440",
                    "r441",
                    "r443",
                    "r446",
                    "r447",
                    "r448",
                    "r449",
                    "r450",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r457",
                    "r458",
                    "r459",
                    "r462",
                    "r522"
                    ]
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementOfCashFlowsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementOfFinancialPositionAbstract",
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementOfStockholdersEquityAbstract",
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementTable",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/BalanceSheetsParenthetical",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement [Table]",
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
                            }
                        }
                    },
                "auth_ref":  [
                    "r146",
                    "r147",
                    "r148",
                    "r169",
                    "r340",
                    "r389",
                    "r410",
                    "r416",
                    "r417",
                    "r418",
                    "r419",
                    "r420",
                    "r421",
                    "r424",
                    "r427",
                    "r428",
                    "r429",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r437",
                    "r438",
                    "r439",
                    "r440",
                    "r441",
                    "r443",
                    "r446",
                    "r447",
                    "r448",
                    "r449",
                    "r450",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r457",
                    "r458",
                    "r459",
                    "r462",
                    "r522"
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net proceeds from ATM, shares",
                            "verboseLabel":  "Net proceeds from ATM in shares",
                            "documentation":  "Number of new stock issued during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r62",
                    "r63",
                    "r89",
                    "r394",
                    "r462",
                    "r480"
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exercise of stock options, shares",
                            "documentation":  "Number of share options (or share units) exercised during the current period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r62",
                    "r63",
                    "r89",
                    "r261"
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net proceeds from ATM",
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r62",
                    "r63",
                    "r89",
                    "r399",
                    "r462",
                    "r480",
                    "r528"
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodValueStockOptionsExercised",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exercise of stock options",
                            "documentation":  "Value of stock issued as a result of the exercise of stock options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r24",
                    "r89"
                    ]
                },
            "us-gaap_StockholdersEquity":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockholdersEquity",
                "crdr":  "credit",
                "calculation":  {
                    "http://biomerica.com/role/BalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets",
                    "http://biomerica.com/role/StatementsOfShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Total Shareholders\u2019 Equity",
                            "periodStartLabel":  "Balances",
                            "periodEndLabel":  "Balances",
                            "label":  "Equity, Attributable to Parent",
                            "documentation":  "Amount of equity (deficit) attributable to parent.  Excludes temporary equity and equity attributable to noncontrolling interest."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63",
                    "r66",
                    "r67",
                    "r85",
                    "r426",
                    "r442",
                    "r463",
                    "r464",
                    "r516",
                    "r529",
                    "r569",
                    "r575",
                    "r586",
                    "r603"
                    ]
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockholdersEquityAbstract",
                "presentation":  [
                    "http://biomerica.com/role/BalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shareholders\u2019 Equity:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SHAREHOLDERS\u2019 EQUITY",
                            "documentation":  "The entire disclosure for equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r88",
                    "r144",
                    "r232",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r243",
                    "r244",
                    "r246",
                    "r302",
                    "r465",
                    "r466",
                    "r484"
                    ]
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventsTextBlock",
                "presentation":  [
                    "http://biomerica.com/role/SubsequentEvents"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SUBSEQUENT EVENTS",
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
                            }
                        }
                    },
                "auth_ref":  [
                    "r334",
                    "r335"
                    ]
                },
            "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
                            "documentation":  "Different names of stock transactions and the different attributes of each transaction."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsidiarySaleOfStockAxis",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative",
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of Stock [Axis]",
                            "documentation":  "Information by type of sale of the entity's stock."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SubsidiarySaleOfStockLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsidiarySaleOfStockLineItems",
                "presentation":  [
                    "http://biomerica.com/role/ShareholdersEquityDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsidiary, Sale of Stock [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SupplementalCashFlowInformationAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SupplementalCashFlowInformationAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Disclosure of Cash Flow Information:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SupplierConcentrationRiskMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SupplierConcentrationRiskMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplier Concentration Risk [Member]",
                            "documentation":  "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services.  Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services."
                            }
                        }
                    },
                "auth_ref":  [
                    "r36"
                    ]
                },
            "BMRA_ThreeKeyCustomersMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "ThreeKeyCustomersMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Three Key Customers [Member]",
                            "documentation":  "Three Key Customers [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_TradeAndOtherAccountsReceivablePolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TradeAndOtherAccountsReceivablePolicy",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ACCOUNTS RECEIVABLE",
                            "documentation":  "Disclosure of accounting policy for accounts receivable."
                            }
                        }
                    },
                "auth_ref":  [
                    "r97",
                    "r98",
                    "r99",
                    "r200",
                    "r201",
                    "r202"
                    ]
                },
            "dei_TradingSymbol":  {
                "xbrltype":  "tradingSymbolItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "TradingSymbol",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Trading Symbol",
                            "documentation":  "Trading symbol of an instrument as listed on an exchange."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_TwoKeyVendorsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "TwoKeyVendorsMember",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Two Key Vendors [Member]",
                            "documentation":  "Two Key Vendors [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_UseOfEstimates":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "UseOfEstimates",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ACCOUNTING ESTIMATES",
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
                            }
                        }
                    },
                "auth_ref":  [
                    "r38",
                    "r39",
                    "r40",
                    "r103",
                    "r104",
                    "r107",
                    "r108"
                    ]
                },
            "us-gaap_VariableLeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "VariableLeaseCost",
                "crdr":  "debit",
                "calculation":  {
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails":  {
                        "parentTag":  "us-gaap_LeaseCost",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://biomerica.com/role/ScheduleOfOperatingLeasesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Variable lease cost",
                            "documentation":  "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
                            }
                        }
                    },
                "auth_ref":  [
                    "r326",
                    "r515"
                    ]
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Diluted",
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r160",
                    "r166"
                    ]
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "WeightedAverageNumberOfSharesOutstandingAbstract",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted average number of common and common equivalent shares:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfOperationsAndComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Basic",
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r159",
                    "r166"
                    ]
                },
            "BMRA_WorkingCapital":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "WorkingCapital",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/SignificantAccountingPoliciesDetailsNarrative"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Working capital",
                            "documentation":  "Working capital.",
                            "label":  "WorkingCapital"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_WriteOffOfIntangibleAssetsAccumulatedAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "WriteOffOfIntangibleAssetsAccumulatedAmortization",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Write off of intangible assets, accumulated amortization",
                            "documentation":  "Write off of intangible assets, accumulated amortization."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "BMRA_WriteOffOfIntangibleAssetsCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://biomerica.com/20240229",
                "localname":  "WriteOffOfIntangibleAssetsCost",
                "crdr":  "credit",
                "presentation":  [
                    "http://biomerica.com/role/StatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Write off of intangible assets, cost",
                            "documentation":  "Write off of intangible assets, cost."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_WrittenCommunications":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "WrittenCommunications",
                "presentation":  [
                    "http://biomerica.com/role/Cover"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Written Communications",
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r548"
                    ]
                }
            }
        }
    },
"std_ref":  {
    "r0":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "25",
        "Paragraph":  "1",
        "SubTopic":  "20",
        "Topic":  "940",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
        },
    "r1":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "SubTopic":  "230",
        "Topic":  "830",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
        },
    "r2":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10A",
        "SubTopic":  "10",
        "Topic":  "220",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
        },
    "r3":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10A",
        "Subparagraph":  "(a-c)",
        "SubTopic":  "10",
        "Topic":  "220",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
        },
    "r4":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "14",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "230",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
        },
    "r5":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "230",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r6":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "230",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r7":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "SubTopic":  "10",
        "Topic":  "360",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
        },
    "r8":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "SubTopic":  "30",
        "Topic":  "350",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r9":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1A",
        "Subparagraph":  "(c),(3)",
        "SubTopic":  "10",
        "Topic":  "810",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
        },
    "r10":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "SubTopic":  "10",
        "Topic":  "505",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
        },
    "r11":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "SubTopic":  "10",
        "Topic":  "820",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
        },
    "r12":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r13":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r14":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2A",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
        },
    "r15":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "SubTopic":  "30",
        "Topic":  "350",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
        },
    "r16":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "41",
        "Subparagraph":  "a",
        "SubTopic":  "10",
        "Topic":  "280",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
        },
    "r17":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(19)",
        "SubTopic":  "10",
        "Topic":  "210",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r18":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
        },
    "r19":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.19,20)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r20":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r21":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r22":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r23":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r24":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r25":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "220",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
        },
    "r26":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "220",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "14A",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
        },
    "r27":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "220",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
        },
    "r28":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
        },
    "r29":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "25",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
        },
    "r30":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
        },
    "r31":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
        },
    "r32":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
        },
    "r33":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "260",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r34":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "260",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
        },
    "r35":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
        },
    "r36":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
        },
    "r37":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
        },
    "r38":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
        },
    "r39":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
        },
    "r40":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
        },
    "r41":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "280",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
        },
    "r42":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "330",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB TOPIC 5.BB)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
        },
    "r43":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "20",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
        },
    "r44":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
        },
    "r45":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
        },
    "r46":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r47":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "((a)(1),(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r48":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r49":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r50":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "360",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
        },
    "r51":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r52":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "20",
        "Section":  "55",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
        },
    "r53":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "20",
        "Section":  "55",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
        },
    "r54":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "810",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
        },
    "r55":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "820",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
        },
    "r56":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "820",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
        },
    "r57":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "825",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
        },
    "r58":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "825",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "21",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
        },
    "r59":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "942",
        "SubTopic":  "210",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r60":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "942",
        "SubTopic":  "825",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
        },
    "r61":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "985",
        "SubTopic":  "20",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
        },
    "r62":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r63":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r64":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r65":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r66":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r67":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r68":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r69":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r70":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r71":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r72":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
        },
    "r73":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r74":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r75":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r76":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.1,2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r77":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r78":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r79":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r80":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "13",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
        },
    "r81":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
        },
    "r82":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
        },
    "r83":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r84":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "235",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//235/tableOfContent"
        },
    "r85":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
        },
    "r86":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "330",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.L)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480581/330-10-S99-1"
        },
    "r87":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "440",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//440/tableOfContent"
        },
    "r88":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "505",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//505/tableOfContent"
        },
    "r89":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.3-04)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
        },
    "r90":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "805",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "38",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
        },
    "r91":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "805",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
        },
    "r92":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r93":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r94":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r95":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r96":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04.1-5)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r97":  {
        "role":  "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11B",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "310",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
        },
    "r98":  {
        "role":  "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(d)",
        "SubTopic":  "10",
        "Topic":  "310",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481962/310-10-50-15"
        },
    "r99":  {
        "role":  "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "SubTopic":  "10",
        "Topic":  "310",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481962/310-10-50-6"
        },
    "r100":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "SubTopic":  "20",
        "Topic":  "740",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
        },
    "r101":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "6",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "270",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
        },
    "r102":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "SubTopic":  "35",
        "Topic":  "720",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
        },
    "r103":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
        },
    "r104":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
        },
    "r105":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
        },
    "r106":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "SubTopic":  "360",
        "Topic":  "958",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
        },
    "r107":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
        },
    "r108":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "12",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
        },
    "r109":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "SubTopic":  "360",
        "Topic":  "958",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
        },
    "r110":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(h))",
        "SubTopic":  "10",
        "Topic":  "235",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r111":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Section":  "1402",
        "Paragraph":  "(a)",
        "Publisher":  "SEC"
        },
    "r112":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "105",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
        },
    "r113":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "205",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
        },
    "r114":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
        },
    "r115":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
        },
    "r116":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
        },
    "r117":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r118":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(16))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r119":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r120":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r121":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r122":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r123":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r124":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(3)(a)(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r125":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30)(a)(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r126":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r127":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r128":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r129":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1A",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
        },
    "r130":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1A",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
        },
    "r131":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1B",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
        },
    "r132":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1B",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
        },
    "r133":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
        },
    "r134":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
        },
    "r135":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
        },
    "r136":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
        },
    "r137":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r138":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(24))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r139":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r140":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r141":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
        },
    "r142":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
        },
    "r143":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
        },
    "r144":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r145":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r146":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "23",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
        },
    "r147":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
        },
    "r148":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
        },
    "r149":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r150":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r151":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
        },
    "r152":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
        },
    "r153":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
        },
    "r154":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
        },
    "r155":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r156":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r157":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
        },
    "r158":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
        },
    "r159":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
        },
    "r160":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
        },
    "r161":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
        },
    "r162":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
        },
    "r163":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "60B",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
        },
    "r164":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "60B",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
        },
    "r165":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
        },
    "r166":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r167":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r168":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
        },
    "r169":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
        },
    "r170":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
        },
    "r171":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
        },
    "r172":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//280/tableOfContent"
        },
    "r173":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
        },
    "r174":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "21",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
        },
    "r175":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "21",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
        },
    "r176":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r177":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r178":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r179":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r180":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(h)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r181":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "26",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
        },
    "r182":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r183":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r184":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r185":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
        },
    "r186":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r187":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r188":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r189":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r190":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r191":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r192":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "34",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
        },
    "r193":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
        },
    "r194":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
        },
    "r195":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "41",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
        },
    "r196":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "41",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
        },
    "r197":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
        },
    "r198":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
        },
    "r199":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
        },
    "r200":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481962/310-10-50-1"
        },
    "r201":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
        },
    "r202":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
        },
    "r203":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r204":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r205":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r206":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r207":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r208":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "5",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
        },
    "r209":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
        },
    "r210":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "330",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//330/tableOfContent"
        },
    "r211":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "330",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
        },
    "r212":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "330",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
        },
    "r213":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r214":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r215":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r216":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r217":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "440",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
        },
    "r218":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "440",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
        },
    "r219":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
        },
    "r220":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
        },
    "r221":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
        },
    "r222":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.Y.Q4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
        },
    "r223":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r224":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r225":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r226":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r227":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r228":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r229":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r230":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r231":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r232":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r233":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r234":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r235":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(g)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r236":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(h)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r237":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r238":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "14",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
        },
    "r239":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "14",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
        },
    "r240":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "14",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
        },
    "r241":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "16",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
        },
    "r242":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
        },
    "r243":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
        },
    "r244":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
        },
    "r245":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
        },
    "r246":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.3-04)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
        },
    "r247":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
        },
    "r248":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
        },
    "r249":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
        },
    "r250":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
        },
    "r251":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
        },
    "r252":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r253":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(n)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r254":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "80",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
        },
    "r255":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//718/tableOfContent"
        },
    "r256":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
        },
    "r257":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r258":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r259":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r260":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r261":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r262":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r263":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r264":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r265":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r266":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r267":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r268":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r269":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(v)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r270":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(h)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r271":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "15",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
        },
    "r272":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "15",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
        },
    "r273":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "15",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
        },
    "r274":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.C.Q3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r275":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.D.1.Q5)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r276":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.D.2.Q6)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r277":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.D.3.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r278":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r279":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "720",
        "SubTopic":  "35",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
        },
    "r280":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "730",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "05",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
        },
    "r281":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "730",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
        },
    "r282":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
        },
    "r283":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
        },
    "r284":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
        },
    "r285":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "17",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
        },
    "r286":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
        },
    "r287":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
        },
    "r288":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
        },
    "r289":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(d)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r290":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(d)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r291":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
        },
    "r292":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
        },
    "r293":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
        },
    "r294":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(bb)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
        },
    "r295":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
        },
    "r296":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r297":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r298":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r299":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r300":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r301":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(i)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r302":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
        },
    "r303":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r304":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r305":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r306":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
        },
    "r307":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//830/tableOfContent"
        },
    "r308":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481839/830-10-45-9"
        },
    "r309":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482014/830-20-35-3"
        },
    "r310":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-12"
        },
    "r311":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
        },
    "r312":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r313":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r314":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r315":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r316":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
        },
    "r317":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//842-20/tableOfContent"
        },
    "r318":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
        },
    "r319":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
        },
    "r320":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
        },
    "r321":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
        },
    "r322":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
        },
    "r323":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r324":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r325":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r326":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r327":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r328":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r329":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r330":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
        },
    "r331":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "848",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
        },
    "r332":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r333":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r334":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "855",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//855/tableOfContent"
        },
    "r335":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "855",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
        },
    "r336":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r337":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "910",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
        },
    "r338":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "912",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "11",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
        },
    "r339":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "912",
        "SubTopic":  "330",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
        },
    "r340":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "924",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
        },
    "r341":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "926",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
        },
    "r342":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "928",
        "SubTopic":  "340",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
        },
    "r343":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
        },
    "r344":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
        },
    "r345":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
        },
    "r346":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
        },
    "r347":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
        },
    "r348":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
        },
    "r349":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "33",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
        },
    "r350":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "33",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
        },
    "r351":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "35A",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
        },
    "r352":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "35A",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
        },
    "r353":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
        },
    "r354":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
        },
    "r355":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(26))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r356":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r357":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
        },
    "r358":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
        },
    "r359":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(1)(h))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r360":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r361":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(19))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r362":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(21))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r363":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(22))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r364":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r365":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r366":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r367":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(8)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r368":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r369":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(11))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r370":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r371":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(22))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r372":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r373":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(3)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r374":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r375":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column A))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r376":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column B))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r377":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column C))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r378":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column D))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r379":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column E))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r380":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column F))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r381":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7A",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
        },
    "r382":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r383":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r384":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r385":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r386":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r387":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(h)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r388":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "825",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
        },
    "r389":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r390":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(f)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r391":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(f)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r392":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(f)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r393":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(h)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r394":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r395":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(2)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r396":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(2)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r397":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r398":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
        },
    "r399":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
        },
    "r400":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
        },
    "r401":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "27",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
        },
    "r402":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r403":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r404":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r405":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r406":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r407":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r408":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(g)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r409":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(h)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
        },
    "r410":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
        },
    "r411":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
        },
    "r412":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
        },
    "r413":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r414":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r415":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r416":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r417":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(12)(b)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r418":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(12)(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r419":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(12)(b)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r420":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(13)(a)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r421":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(13)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r422":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(14))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r423":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(15))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r424":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(16)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r425":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(17))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r426":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(19))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r427":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(2)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r428":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(2)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r429":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(3)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r430":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(3)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r431":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(3)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r432":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r433":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r434":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r435":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(e))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r436":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(8))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r437":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r438":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r439":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r440":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(e))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r441":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.6-05(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
        },
    "r442":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.6-05(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
        },
    "r443":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
        },
    "r444":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
        },
    "r445":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
        },
    "r446":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r447":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r448":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r449":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r450":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r451":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r452":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r453":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r454":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r455":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r456":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r457":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r458":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r459":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r460":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r461":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(1)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r462":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(4)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r463":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r464":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r465":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
        },
    "r466":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
        },
    "r467":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
        },
    "r468":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-12(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
        },
    "r469":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-12(Column C)(Footnote 5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
        },
    "r470":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "12",
        "Subparagraph":  "(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
        },
    "r471":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "19",
        "Subparagraph":  "(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
        },
    "r472":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-12A(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
        },
    "r473":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-12A(Column C)(Footnote 4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
        },
    "r474":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 4)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r475":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 4)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r476":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r477":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Subparagraph":  "(SX 210.12-14(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
        },
    "r478":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Subparagraph":  "(SX 210.12-14(Column F)(Footnote 7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
        },
    "r479":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
        },
    "r480":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
        },
    "r481":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
        },
    "r482":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
        },
    "r483":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
        },
    "r484":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
        },
    "r485":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "948",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-29(Footnote 4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
        },
    "r486":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "954",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
        },
    "r487":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "954",
        "SubTopic":  "440",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
        },
    "r488":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column B))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r489":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column C))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r490":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column D))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r491":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column E))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r492":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column F))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r493":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column G))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r494":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column H))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r495":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Column I))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r496":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "970",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-28(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
        },
    "r497":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "976",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
        },
    "r498":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "978",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
        },
    "r499":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(e)",
        "SubTopic":  "10",
        "Topic":  "235",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
        },
    "r500":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "13H",
        "Subparagraph":  "(a)",
        "SubTopic":  "40",
        "Topic":  "944",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
        },
    "r501":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "13H",
        "Subparagraph":  "(b)",
        "SubTopic":  "40",
        "Topic":  "944",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
        },
    "r502":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
        },
    "r503":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
        },
    "r504":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
        },
    "r505":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
        },
    "r506":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
        },
    "r507":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
        },
    "r508":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r509":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
        },
    "r510":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "12A",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
        },
    "r511":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r512":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "91",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
        },
    "r513":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "91",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
        },
    "r514":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "715",
        "SubTopic":  "80",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
        },
    "r515":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
        },
    "r516":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "852",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
        },
    "r517":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "944",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
        },
    "r518":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
        },
    "r519":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
        },
    "r520":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r521":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
        },
    "r522":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
        },
    "r523":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-12(Column A)(Footnote 2)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
        },
    "r524":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-12A(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
        },
    "r525":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 1)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r526":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Subparagraph":  "(SX 210.12-14(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
        },
    "r527":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
        },
    "r528":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
        },
    "r529":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
        },
    "r530":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12"
        },
    "r531":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r532":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r533":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "b-23"
        },
    "r534":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r535":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "g"
        },
    "r536":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12, 13, 15d"
        },
    "r537":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "13e",
        "Subsection":  "4c"
        },
    "r538":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "14d",
        "Subsection":  "2b"
        },
    "r539":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "15",
        "Subsection":  "d"
        },
    "r540":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Section":  "14a",
        "Number":  "240",
        "Subsection":  "12"
        },
    "r541":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 10-K",
        "Number":  "249",
        "Section":  "310"
        },
    "r542":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r543":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 20-F",
        "Number":  "249",
        "Section":  "220",
        "Subsection":  "f"
        },
    "r544":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 40-F",
        "Number":  "249",
        "Section":  "240",
        "Subsection":  "f"
        },
    "r545":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r546":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Section":  "405"
        },
    "r547":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Securities Act",
        "Number":  "230",
        "Section":  "405"
        },
    "r548":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Securities Act",
        "Number":  "230",
        "Section":  "425"
        },
    "r549":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Securities Act",
        "Number":  "7A",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r550":  {
        "role":  "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
        },
    "r551":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
        },
    "r552":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1B",
        "SubTopic":  "825",
        "Topic":  "944",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
        },
    "r553":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(1)",
        "SubTopic":  "20",
        "Topic":  "842",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r554":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4H",
        "SubTopic":  "40",
        "Topic":  "944",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
        },
    "r555":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "705",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//705/tableOfContent"
        },
    "r556":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r557":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r558":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r559":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6)(a)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r560":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r561":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r562":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r563":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
        },
    "r564":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
        },
    "r565":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
        },
    "r566":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r567":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r568":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r569":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r570":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "23",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
        },
    "r571":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
        },
    "r572":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
        },
    "r573":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "55",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
        },
    "r574":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
        },
    "r575":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r576":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "410",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "10",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
        },
    "r577":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "450",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//450/tableOfContent"
        },
    "r578":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
        },
    "r579":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
        },
    "r580":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r581":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r582":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "470",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1B",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
        },
    "r583":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
        },
    "r584":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
        },
    "r585":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r586":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
        },
    "r587":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "830",
        "SubTopic":  "230",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
        },
    "r588":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r589":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
        },
    "r590":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
        },
    "r591":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "852",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
        },
    "r592":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "852",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
        },
    "r593":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r594":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r595":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r596":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
        },
    "r597":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
        },
    "r598":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
        },
    "r599":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "912",
        "SubTopic":  "730",
        "Name":  "Accounting Standards Codification",
        "Section":  "25",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
        },
    "r600":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "944",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2B",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
        },
    "r601":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
        },
    "r602":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(18))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r603":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(4)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r604":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r605":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-12(Column A)(Footnote 2)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
        },
    "r606":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-12A(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
        },
    "r607":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 1)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r608":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Subparagraph":  "(SX 210.12-14(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
        },
    "r609":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "39",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480228/946-830-45-39"
        }
    }
}


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/10/24  Biomerica Inc.                    424B5                  1:270K                                   M2 Compliance LLC/FA
Top
Filing Submission 0001493152-24-014474   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 3:19:21.4am ET